Find Suvecaltamide manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Mk-8998, 953778-58-0, (r)-2-(4-isopropylphenyl)-n-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide, Jzp385, Cx-8998, Suvecaltamide [usan]
Molecular Formula
C20H23F3N2O2
Molecular Weight
380.4  g/mol
InChI Key
IQIKXZMPPBEWAD-CQSZACIVSA-N
FDA UNII
MIA4WMP8QN

Suvecaltamide
1 2D Structure

Suvecaltamide

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-(4-propan-2-ylphenyl)-N-[(1R)-1-[5-(2,2,2-trifluoroethoxy)pyridin-2-yl]ethyl]acetamide
2.1.2 InChI
InChI=1S/C20H23F3N2O2/c1-13(2)16-6-4-15(5-7-16)10-19(26)25-14(3)18-9-8-17(11-24-18)27-12-20(21,22)23/h4-9,11,13-14H,10,12H2,1-3H3,(H,25,26)/t14-/m1/s1
2.1.3 InChI Key
IQIKXZMPPBEWAD-CQSZACIVSA-N
2.1.4 Canonical SMILES
CC(C)C1=CC=C(C=C1)CC(=O)NC(C)C2=NC=C(C=C2)OCC(F)(F)F
2.1.5 Isomeric SMILES
C[C@H](C1=NC=C(C=C1)OCC(F)(F)F)NC(=O)CC2=CC=C(C=C2)C(C)C
2.2 Other Identifiers
2.2.1 UNII
MIA4WMP8QN
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Mk-8998

2. 953778-58-0

3. (r)-2-(4-isopropylphenyl)-n-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide

4. Jzp385

5. Cx-8998

6. Suvecaltamide [usan]

7. Jzp-385

8. Mia4wmp8qn

9. Chembl1684950

10. Mk8998

11. 2-(4-propan-2-ylphenyl)-n-[(1r)-1-[5-(2,2,2-trifluoroethoxy)pyridin-2-yl]ethyl]acetamide

12. Benzeneacetamide, 4-(1-methylethyl)-n-((1r)-1-(5-(2,2,2-trifluoroethoxy)-2-pyridinyl)ethyl)-

13. Mk-8998 Free Base

14. 2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide

15. 2-(4-isopropylphenyl)-n-[(1r)-1-[5-(2,2,2-trifluoroethoxy)pyridin-2-yl]ethyl]acetamide

16. Unii-mia4wmp8qn

17. Suvecaltamide [inn]

18. Suvecaltamide [who-dd]

19. Schembl1065999

20. Gtpl12648

21. Glxc-10813

22. Bcp18693

23. Ex-a2479

24. Bdbm50192668

25. Who 11291

26. Akos032945005

27. Compound 1 [pmid: 27579577]

28. Compound 1 [pmid: 34582192]

29. Cs-6198

30. Ac-35480

31. Bs-17962

32. Cid 24765479

33. Mk-8998?

34. Db-362320

35. Hy-101096

36. C77290

37. A922518

38. 4-(1-methylethyl)-n-((1r)-1-(5-(2,2,2-trifluoroethoxy)-2-pyridinyl)ethyl)benzeneacetamide

2.4 Create Date
2008-04-21
3 Chemical and Physical Properties
Molecular Weight 380.4 g/mol
Molecular Formula C20H23F3N2O2
XLogP34.2
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count7
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area51.2
Heavy Atom Count27
Formal Charge0
Complexity463
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty